Medipharm SRL
3.8 FTEThe score of Medipharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +19 % Total assets -22 % Headcount (avg FTE) -24 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medipharm's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Medipharm's financial analysis
- Solvency57.8%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medipharm
Medipharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0859.994.080
- VAT number
- BE0859994080
- Peppol
- Registered · 0208:0859994080 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Aug 2003
- Registered office
- 1140 Evere
- Size
- Micro · 3.8 FTE
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Medipharm (SRL) has been based in Evere since 2003, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 843 € and equity of 336,778 €; its revenue is not published. With 3.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 57.8%, above the median of its sector (37.8%).
Companies similar to Medipharm
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Suys Retail sale of pharmaceutical products Laarne · balance sheet 583,450 €
- Eeuwfeestapotheek Retail sale of pharmaceutical products Antwerp · balance sheet 583,835 €
- Maertens Pharma Associes Retail sale of pharmaceutical products Chimay · balance sheet 583,944 €
- Beirnaert VG Retail sale of pharmaceutical products Destelbergen · balance sheet 584,335 €
- Pharmacie DE Jalhay Retail sale of pharmaceutical products Chaudfontaine · balance sheet 584,400 €
- Belpharma Retail sale of pharmaceutical products Namur · balance sheet 581,313 €
- Pharmax Retail sale of pharmaceutical products Liège · balance sheet 586,278 €
- Farmafleur Retail sale of pharmaceutical products Antwerp · balance sheet 542,076 €
Frequently asked questions about Medipharm
What is the revenue of Medipharm?
Medipharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medipharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0859994080 for Medipharm, if the company is VAT-registered. Its company number (CBE) is 0859.994.080.
Where is the registered office of Medipharm?
According to the CBE register, the registered office of Medipharm is in 1140 Evere.
What is the equity of Medipharm?
At the close of the 2025 financial year, the equity of Medipharm amounts to 336,778 €, a solvency of 57.8% of total assets.
How many people work at Medipharm?
3.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Medipharm?
The register lists 1 active mandates at Medipharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medipharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →